A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

NCT01006122 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer